DMBT1 Confers Mucosal Protection In Vivo and a Deletion Variant Is Associated With Crohn's Disease

Gastroenterology

Volumn 133, Issue 5, 2007, Pages 1499-1509

  Renner, Marcus ^a   Bergmann, Gaby ^a   Krebs, Inge ^a   End, Caroline ^a,b   Lyer, Stefan ^a   Hilberg, Frank ^c   Helmke, Burkhard ^d   Gassler, Nikolaus ^d   Autschbach, Frank ^d   Bikker, Floris ^a,e   Strobel Freidekind, Olga ^a   Gronert Sum, Sabine ^a   Benner, Axel ^a   Blaich, Stephanie ^a   Wittig, Rainer ^a   Hudler, Melanie ^a   Ligtenberg, Antoon J ^e   Madsen, Jens ^f   Holmskov, Uffe ^f   Annese, Vito ^g   Latiano, Anna ^g   Schirmacher, Peter ^d   Amerongen, Arie V Nieuw ^e   D'Amato, Mauro ^h   Kioschis, Petra ^b   Hafner, Mathias ^b   Poustka, Annemarie ^a   Mollenhauer, Jan ^a   more..

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b MANNHEIM UNIVERSITY OF APPLIED SCIENCES   (Germany)

^c BOEHRINGER INGELHEIM RCV GMBH AND CO KG   (Austria)

^d UNIVERSITY OF HEIDELBERG   (Germany)

^e UNIVERSITY OF AMSTERDAM   (Netherlands)

^f UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^g CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^h KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

DELETED IN MALIGNANT BRAIN TUMORS 1; DEXTRAN SULFATE; MESSENGER RNA; PROTEIN; SCAVENGER RECEPTOR; UNCLASSIFIED DRUG;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CASE CONTROL STUDY; CELL SURFACE; CLINICAL ARTICLE; COLITIS; COLON MUCOSA; CONTROLLED STUDY; CROHN DISEASE; DISEASE ACTIVITY; ENTERITIS; FEMALE; GENE; GENE DELETION; GENE EXPRESSION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; IN VIVO STUDY; INTESTINE EPITHELIUM CELL; MALE; MOUSE; NONHUMAN; PANETH CELL; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK FACTOR; UPREGULATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANIMALS; CASE-CONTROL STUDIES; CHILD; CROHN DISEASE; DEXTRAN SULFATE; DISEASE SUSCEPTIBILITY; EXONS; FEMALE; GENE DELETION; HUMANS; INTERLEUKIN-6; INTESTINAL MUCOSA; MALE; MICE; MICE, TRANSGENIC; MIDDLE AGED; MUCINS; NOD2 SIGNALING ADAPTOR PROTEIN; RECEPTORS, CELL SURFACE; RISK FACTORS; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 35649016207     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2007.08.007     Document Type: Article

References (47)

1. Probert C.S., Jayanthi V., Rampton D.S., et al. Epidemiology of inflammatory bowel disease in different ethnic and religious groups: limitations and aetiological clues. Int J Colorectal Dis 11 (1996) 25-28
2. Shivananda S., Lennard-Jones J., Logan R., et al. Incidence of inflammatory bowel disease across Europe: is there a difference between north and south?. Results of the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD). Gut 39 (1996) 690-697
3. Schreiber S., Rosenstiel P., Albrecht M., et al. Genetics of Crohn disease an archetypal inflammatory barrier disease. Nat Rev Genet 6 (2005) 376-388
4. Karlinger K., Gyorke T., Mako E., et al. The epidemiology and the pathogenesis of inflammatory bowel disease. Eur J Radiol 35 (2000) 154-167
5. Ogura Y., Bonen D.K., Inohara N., et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 411 (2001) 603-606
6. Hugot J.P., Chamaillard M., Zouali H., et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 411 (2001) 599-603
7. Hampe J., Cuthbert A., Croucher P.J., et al. Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations. Lancet 357 (2001) 1925-1928
8. Watanabe T., Kitani A., Murray P.J., et al. NOD2 is a negative regulator of Toll-like receptor 2-mediated T helper type 1 responses. Nat Immunol 5 (2004) 800-808
9. Maeda S., Hsu L.C., Liu H., et al. Nod2 mutation in Crohn's disease potentiates NF-kappaB activity and IL-1beta processing. Science 307 (2005) 734-738
10. Kobayashi K.S., Chamaillard M., Ogura Y., et al. Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract. Science 307 (2005) 731-734
11. Fellermann K., Stange D.E., Schaeffeler E., et al. A chromosome 8 gene-cluster polymorphism with low human beta-defensin 2 gene copy number predisposes to Crohn disease of the colon. Am J Hum Genet 79 (2006) 439-448
12. Noble C., Nimmo E., Gaya D., et al. Novel susceptibility genes in inflammatory bowel disease. World J Gastroenterol 12 (2006) 1991-1999
13. Mollenhauer J., Wiemann S., Scheurlen W., et al. DMBT1, a new member of the SRCR superfamily, on chromosome 10q25.3-26.1 is deleted in malignant brain tumours. Nat Genet 17 (1997) 32-39
14. Mollenhauer J., Herbertz S., Holmskov U., et al. DMBT1 encodes a protein involved in the immune defense and in epithelial differentiation and is highly unstable in cancer. Cancer Res 60 (2000) 1704-1710
15. Mollenhauer J., Helmke B., Medina D., et al. Carcinogen inducibility in vivo and down-regulation of DMBT1 during breast carcinogenesis. Genes Chromosomes Cancer 39 (2004) 185-194
16. Wu W., Kemp B.L., Proctor M.L., et al. Expression of DMBT1, a candidate tumor suppressor gene, is frequently lost in lung cancer. Cancer Res 59 (1999) 1846-1851
17. Mollenhauer J., Helmke B., Muller H., et al. Sequential changes of the DMBT1 expression and location in normal lung tissue and lung carcinomas. Genes Chromosomes Cancer 35 (2002) 164-169
18. Mori M., Shiraishi T., Tanaka S., et al. Lack of DMBT1 expression in oesophageal, gastric and colon cancers. Br J Cancer 79 (1999) 211-213
19. Mollenhauer J., Herbertz S., Helmke B., et al. Deleted in Malignant Brain Tumors 1 is a versatile mucin-like molecule likely to play a differential role in digestive tract cancer. Cancer Res 61 (2001) 8880-8886
20. Vijayakumar S., Takito J., Hikita C., et al. Hensin remodels the apical cytoskeleton and induces columnarization of intercalated epithelial cells: processes that resemble terminal differentiation. J Cell Biol 144 (1999) 1057-1067
21. Hikita C., Vijayakumar S., Takito J., et al. Induction of terminal differentiation in epithelial cells requires polymerization of hensin by galectin 3. J Cell Biol 151 (2000) 1235-1246
22. Takito J., and Al-Awqati Q. Conversion of ES cells to columnar epithelia by hensin and to squamous epithelia by laminin. J Cell Biol 166 (2004) 1093-1102
23. Holmskov U., Mollenhauer J., Madsen J., et al. Cloning of gp-340, a putative opsonin receptor for lung surfactant protein D. Proc Natl Acad Sci U S A 96 (1999) 10794-10799
24. Prakobphol A., Xu F., Hoang V.M., et al. Salivary agglutinin, which binds Streptococcus mutans and Helicobacter pylori, is the lung scavenger receptor cysteine-rich protein gp-340. J Biol Chem 275 (2000) 39860-39866
25. Bikker F.J., Ligtenberg A.J., Nazmi K., et al. Identification of the bacteria-binding peptide domain on salivary agglutinin (gp-340/DMBT1), a member of the scavenger receptor cysteine-rich superfamily. J Biol Chem 277 (2002) 32109-32115
26. Hartshorn K.L., White M.R., Mogues T., et al. Lung and salivary scavenger receptor glycoprotein-340 contribute to the host defense against influenza A viruses. Am J Physiol Lung Cell Mol Physiol 285 (2003) L1066-L1076
27. Wu Z., Van Ryk D., Davis C., et al. Salivary agglutinin inhibits HIV type 1 infectivity through interaction with viral glycoprotein 120. AIDS Res Hum Retroviruses 19 (2003) 201-209
28. Gassler N., Kopitz J., Tehrani A., et al. Expression of acyl-CoA synthetase 5 reflects the state of villus architecture in human small intestine. J Pathol 202 (2004) 188-196
29. Mollenhauer J., Muller H., Kollender G., et al. The SRCR/SID region of DMBT1 defines a complex multi-allele system representing the major basis for its variability in cancer. Genes Chromosomes Cancer 35 (2002) 242-255
30. Siegmund B., Rieder F., Albrich S., et al. Adenosine kinase inhibitor GP515 improves experimental colitis in mice. J Pharmacol Exp Ther 296 (2001) 99-105
31. Mollenhauer J., Holmskov U., Wiemann S., et al. The genomic structure of the DMBT1 gene: evidence for a region with susceptibility to genomic instability. Oncogene 18 (1999) 6233-6240
32. Mueller A., O'Rourke J., Grimm J., et al. Distinct gene expression profiles characterize the histopathological stages of disease in Helicobacter-induced mucosa-associated lymphoid tissue lymphoma. Proc Natl Acad Sci U S A 100 (2003) 1292-1297
33. Hooper L.V., Wong M.H., Thelin A., et al. Molecular analysis of commensal host-microbial relationships in the intestine. Science 291 (2001) 881-884
34. Rawls J.F., Samuel B.S., and Gordon J.I. Gnotobiotic zebrafish reveal evolutionarily conserved responses to the gut microbiota. Proc Natl Acad Sci U S A 101 (2004) 4596-4601
35. Cooper H.S., Murthy S., Kido K., et al. Dysplasia and cancer in the dextran sulfate sodium mouse colitis model. Relevance to colitis-associated neoplasia in the human: a study of histopathology, β-catenin and p53 expression and the role of inflammation. Carcinogenesis 21 (2000) 757-768
36. Wirtz S., and Neurath M.F. Animal models of intestinal inflammation: new insights into the molecular pathogenesis and immunotherapy of inflammatory bowel disease. Int J Colorectal Dis 15 (2000) 144-160
37. Kitajima S., Takuma S., and Morimoto M. Histological analysis of murine colitis induced by dextran sulfate sodium of different molecular weights. Exp Anim 49 (2000) 9-15
38. Cheng H., Bjerknes M., and Chen H. CRP-ductin: a gene expressed in intestinal crypts and in pancreatic and hepatic ducts. Anat Rec 244 (1996) 327-343
39. De Lisle R.C., Petitt M., Isom K.S., et al. Developmental expression of a mucinlike glycoprotein (MUCLIN) in pancreas and small intestine of CF mice. Am J Physiol 275 (1998) G219-G227
40. Matsushita F., Miyawaki A., and Mikoshiba K. Vomeroglandin/CRP-Ductin is strongly expressed in the glands associated with the mouse vomeronasal organ: identification and characterization of mouse vomeroglandin. Biochem Biophys Res Commun 268 (2000) 275-281
41. Madsen J., Tornoe I., Nielsen O., et al. CRP-ductin, the mouse homologue of gp-340/deleted in malignant brain tumors 1 (DMBT1), binds gram-positive and gram-negative bacteria and interacts with lung surfactant protein D. Eur J Immunol 33 (2003) 2327-2336
42. Berrebi D., Maudinas R., Hugot J.P., et al. Card15 gene overexpression in mononuclear and epithelial cells of the inflamed Crohn's disease colon. Gut 52 (2003) 840-846
43. Lala S., Ogura Y., Osborne C., et al. Crohn's disease and the NOD2 gene: a role for paneth cells. Gastroenterology 125 (2003) 47-57
44. Conrad D.F., Andrews T.D., Carter N.P., et al. A high-resolution survey of deletion polymorphism in the human genome. Nat Genet 38 (2006) 75-81
45. Hinds D.A., Kloek A.P., Jen M., et al. Common deletions and SNPs are in linkage disequilibrium in the human genome. Nat Genet 38 (2006) 82-85
46. McCarroll S.A., Hadnott T.N., Perry G.H., et al. International HapMap Consortium. Common deletion polymorphisms in the human genome. Nat Genet 38 (2006) 86-92
47. De Lisle R.C. Characterization of the major sulfated protein of mouse pancreatic acinar cells: a high molecular weight peripheral membrane glycoprotein of zymogen granules. J Cell Biochem 56 (1994) 385-396